Showing results (431-440 of 547) with videos related to
Sort By:
Pageof 55
Clinical and Translational Radiation Oncology|March 11, 2026
Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapyAndrea R Filippi, Jair Bar, Daniel C Christoph, et al.ERJ Open Research|March 17, 2022
Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panelElena Kum, Gordon H Guyatt, Caroline Munoz, et al.Respiratory Medicine|July 19, 2022
Disease burden in individuals with symptomatic undiagnosed asthma or COPDFatmah F Alhabeeb, G A Whitmore, Katherine L Vandemheen, et al.Chest|September 6, 2024
Impact of Dyspnea on Adults With Respiratory Symptoms Without a Defined DiagnosisJared Bierbrier, Emily Gerstein, George A Whitmore, et al.American Journal of Respiratory and Critical Care Medicine|October 4, 2023
Impact of Undiagnosed Chronic Obstructive Pulmonary Disease and Asthma on Symptoms, Quality of Life, Healthcare Use, and Work ProductivityEmily Gerstein, Jared Bierbrier, G Alex Whitmore, et al.American Journal of Industrial Medicine|January 9, 2024
Prevalent occupational exposures and risk of lung cancer among women: Results from the application of the Canadian Job-Exposure Matrix (CANJEM) to a combined set of ten case-control studiesMengting Xu, Vikki Ho, Jérôme Lavoué, et al.ERJ Open Research|August 5, 2025
Top 10 priorities for chronic cough: Canadian James Lind Alliance Priority-Setting Partnership (CAN-COUGH)Saif Samari, Ana Oliveira, Danica Brister, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2022
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R StudyNicolas Girard, Jair Bar, Pilar Garrido, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2025
Lung Cancer Screening Program Quality Indicators-Review and Recommendations: An International Association for the Study of Lung Cancer Delphi Process StudyMartin C Tammemägi, Andrea Borondy-Kitts, John K Field, et al.ESMO Open|February 5, 2026
Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLCN Girard, J Bar, P Baas, et al.Pageof 55